NA
Insider
Nadim Ahmed
President and CEONadim Ahmed (President and CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Cullinan Therapeutics, Inc. (CGEM). The largest single filing was $223K of CGEM (16,381 sh × $13.62, as filed), executed Feb 20.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$419K
shares × price, as filed
Last traded
Feb 24
Filed Feb 25
Median ADV $20.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $526K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CGEMRecent filings
CGEMSALE
Cullinan Therapeutics, Inc.
View filing →
$196K13,515 sh × $14.47
Exec Feb 24
Filed Feb 25 · 5:30 PM ET CGEMSALE Cullinan Therapeutics, Inc. View filing → $223K
16,381 sh × $13.62
Exec Feb 20
Filed Feb 23 · 5:30 PM ET CGEMSALE Cullinan Therapeutics, Inc. View filing → $107K
12,529 sh × $8.53
Exec Feb 25 2025
Filed Feb 27 2025 · 5:30 PM ET